Best Specialty Pharma Stocks Picked by UBS
UBS Investment Research published a report entitled “UBS Pharma- Large Cap and Specialty” on January 11, 2012. The report isn’t publicy available but we will summarize its main points. In their...
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1.) | Visium Asset Management Jacob Gottlieb |
3,460,000 | $119,474 | +73%![]() |
5.11% |
| 2.) | Harbert Management Raymond J. Harbert |
248,343 | $8,575 | +29%![]() |
3.04% |
| 3.) | Point State Capital Sean Cullinan |
750,000 | $25,898 | ![]() |
1.99% |
| 4.) | Samlyn Capital Robert Pohly |
1,400,185 | $48,349 | -30%![]() |
1.54% |
| 5.) | Maverick Capital Lee Ainslie |
2,958,102 | $102,143 | ![]() |
1.42% |
| Insider | Price | Amount | Relationship | Remaning Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.301 | 8200 | Director | 15522 | 2011-08-25 | Filing | |
| $36.38 | 1000 | Director | 1000 | 2010-12-07 | Filing | |
| $16.31 | 3000 | Director | 6908 | 2009-05-13 | Filing | |
| $16.739 | 28964 | Director | 28964 | 2009-03-10 | Filing |
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $32.31 | 5000 | Director | 0 | 2011-11-08 | Filing | |
| $41.17 | 20588 | Officer | 0 | 2011-07-06 | Filing | |
| $39.39 | 12500 | Officer | 0 | 2011-05-03 | Filing | |
| $39.9 | 35000 | Officer | 0 | 2011-04-05 | Filing | |
| $36 | 1292 | Officer | 0 | 2011-03-03 | Filing |